By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    photo of hands with blue veins
    8 Proven Tips on Finding Difficult Veins
    November 12, 2021
    tips for getting over the pandemic blues
    4 Proven Ways to Get Over the Pandemic Blues
    February 22, 2022
    medical industry innovations
    How is CNC Machining Transforming the Medical Industry?
    June 2, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Doctors on Google: Manhattan Research Survey 2012
    July 23, 2012
    HealthCare’s Need for Transparency Goes Far Beyond Pricing
    December 10, 2012
    Medicare Payments to Providers Are Carved, Sliced and Chopped by Sequestration
    March 25, 2013
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Estimating Lifetime or Episode-of-Illness Costs Under Censoring
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Estimating Lifetime or Episode-of-Illness Costs Under Censoring
Public Health

Estimating Lifetime or Episode-of-Illness Costs Under Censoring

JasonShafrin
Last updated: August 23, 2017 1:30 pm
JasonShafrin
Share
5 Min Read
SHARE

How can you estimate an individual’s total lifetime cost of medical care? For people who die in your sample, this is simple. In most data sets, however, not all individuals will die during the period of observation. Thus, the data set is censored for those who do not die. In addition, many standard hazard models do not allow for researchers to disaggregate the effects of covariates on survival and the intensity of utilization. Both factors have an effect on cost. Assuming that censoring is random, Basu and Manning (2010) describe a method to calculate expected lifetime costs for each individual as follows:

  1. Estimate Survival Probabilities. Use a flexible survival model, such as an accelerated failure time model based on the generalized gamma distribution for time, to estimate the individual’s survival function after taking into account censoring. Let Sj(X) and hj(X) be the estimated survivor function and the hazard function for an interval indexed by j. The observation The predictions are obtained for all time periods for all patients.
  2. Estimate cost among patients who died. Among those subject intervals, (aj-1, aj], where we observe the subject to die, estimate a generalized linear model (or models if a two-part specification is necessary) for the observed costs after conditioning on covariates X. One can also condition on the time of death within the interval as well. Use parameter estimates from this model to predict costs, μ1j(X), for every subject-interval in the data. To account for the stochastic nature of U within that interval (i.e. to account for what would the costs be if the patient died inside that interval but at different times), one simply averages the predictions that are conditional of each value of U after weighting with the observed distribution of U among intervals where patients are observed to die. Therefore, μ1j(X)=∫μ1j(X,U) dF(U|abobsb+1).
  3. Estimate the cost among subjects not observed to die. Next, among those subject intervals, (aj-1, aj], where patients are not observed to die but excluding those where we only observe costs over a partial duration due to censoring, estimate a generalized linear model (or models if a two-part specification is necessary) for the observed cost functions after conditioning on covariates X. We use parameter estimates from this model to predict costs, μ2j(X), for every subject-interval in our data. We do not use the subject intervals where censoring occurs in our estimation in this part. This allows us effectively to allow for continuous censoring times.

  Thus, the resulting cost function for interval j for any individual is given by:

  • μj(X)=Sj(X)*[hj(X)*μ1j(X) + (1-hj(X))*μ2j(X)]

  There are a number of benefits of using this framework. First, Basu and Manning show that this estimator can “decompose the covariate effects on total costs into part mediated by survival effects and another mediated by intensity of use.” Second, this method allows for death to take place any time during each interval rather than solely at the end of an interval. Third, the model “allows for separate estimators to be used for end-of-life and non-end-of-life periods.” The separate estimators are especially useful in cases where end-of-life cost differs significantly from the regular course of care. For instance, one study demonstrated the there is a U-shaped pattern of cost history among cancer patients with the left side of the U corresponding to initial treatment and the right side reflecting a substantial spike in costs during the last 6 months of life. For those interested, Basu and Manning also provide a simulation and empirical application to demonstrate the utility of their econometric specification compared to earlier models.

TAGGED:medical costs
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

Consumers More Choosy About Cars and Appliances than Health Care

December 15, 2011
healthcare data release
Health ReformPolicy & LawPublic Health

Data Alone Does Not Make Health Care Pricing Meaningful

May 10, 2013
Zika Virus
Health ReformPolicy & LawPublic Health

Zika Virus Legislation, Diagnosis, and Prevention: What You Need to Know

July 8, 2016
health cost
Health ReformPolicy & LawPublic Health

Health Insurance Under the Exchanges: What Will You Pay?

June 11, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?